阿昔替尼 Axitinib (Beacon)
阿昔替尼是一种用于治疗肾细胞癌等实体瘤的VEGFR-TKI抑制剂。
- The description claims that axitinib inhibits the VEGFR signaling pathway to cut off tumor blood supply and inhibit tumor growth and metastasis.
Specifications
- 通用名称
- Axitinib, 阿昔替尼
- 剂型
- 片剂
- 剂量
- 1mg, 5mg
AI Readiness
Good foundation, but some important product data is still missing.
69%